Literature DB >> 14715542

Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.

Erik L Munson1, David J DeCoster, Dean T Nardelli, Douglas M England, Steven M Callister, Ronald F Schell.   

Abstract

Development of a high level of sustained borreliacidal antibody is paramount for maintaining protection against infection with Borrelia burgdorferi. We show that production of borreliacidal antibody can be enhanced by preventing the effects of gamma interferon (IFN-gamma). When lymph node cells capable of producing borreliacidal antibody were cultured with anti-murine IFN-gamma, an eightfold increase in borreliacidal antibody production was obtained. However, anti-IFN-gamma treatment of these cells also enhanced their ability to adaptively induce arthritis. When anti-IFN-gamma-treated lymph node cells producing borreliacidal antibody were infused into C3H/HeJ mice and the mice were then challenged with B. burgdorferi, the mice developed severe destructive Lyme arthritis. Additional studies are needed to delineate the immune response responsible for the induction of arthritis and production of borreliacidal antibody. These studies are needed to ensure an effective and safe vaccine against infection with B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715542      PMCID: PMC321347          DOI: 10.1128/cdli.11.1.35-41.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  34 in total

1.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

2.  Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis.

Authors:  S M Callister; R F Schell
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

Review 3.  Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship.

Authors:  S R Paludan
Journal:  Scand J Immunol       Date:  1998-11       Impact factor: 3.487

4.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.

Authors:  M Moskophidis; B Luther
Journal:  Zentralbl Bakteriol       Date:  1993-06

7.  Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.

Authors:  V Sambri; S Armati; R Cevenini
Journal:  FEMS Immunol Med Microbiol       Date:  1993-06

8.  Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.

Authors:  M K Aydintug; Y Gu; M T Philipp
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

10.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  4 in total

1.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.

Authors:  Erik L Munson; Dean T Nardelli; K H Kevin Luk; Monica C Remington; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 4.  Hamster and murine models of severe destructive Lyme arthritis.

Authors:  Erik Munson; Dean T Nardelli; Brian K Du Chateau; Steven M Callister; Ronald F Schell
Journal:  Clin Dev Immunol       Date:  2012-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.